Show simple item record

dc.contributor.authorIserson, Kenneth V.
dc.date.accessioned2020-07-01T19:19:07Z
dc.date.available2020-07-01T19:19:07Z
dc.date.issued2020-06-05
dc.identifier.citationIserson, K. V. (2020). SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward. Cambridge Quarterly of Healthcare Ethics, 1-12.en_US
dc.identifier.issn0963-1801
dc.identifier.doi10.1017/s096318012000047x
dc.identifier.urihttp://hdl.handle.net/10150/641777
dc.description.abstractThe world awaits a SARS-CoV-2 virus (i.e., COVID-19 disease) vaccine to keep the populace healthy, fully reopen their economies, and return their social and healthcare systems to “normal.” Vaccine safety and efficacy requires meticulous testing and oversight; this paper describes how despite grandiose public statements, the current vaccine development, testing, and production methods may prove to be ethically dubious, medically dangerous, and socially volatile. The basic moral concern is the potential danger to the health of human test subjects and, eventually, many vaccine recipients. This is further complicated by economic and political pressures to reduce government oversight on rushed vaccine testing and production, nationalistic distribution goals, and failure to plan for the widespread immunization needed to produce global herd immunity. As this paper asserts, the public must be better informed to assess promises about the novel vaccines being produced and to tolerate delays and uncertainty.en_US
dc.language.isoenen_US
dc.publisherCambridge University Press (CUP)en_US
dc.rights© The Author(s), 2020. Published by Cambridge University Press. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/).en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2 virusen_US
dc.subjectvaccinesen_US
dc.subjectvaccine testingen_US
dc.subjectimmunizationen_US
dc.titleSARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forwarden_US
dc.typeArticleen_US
dc.identifier.eissn1469-2147
dc.contributor.departmentUniv Arizona, Dept Emergency Meden_US
dc.identifier.journalCambridge Quarterly of Healthcare Ethicsen_US
dc.description.noteOpen access articleen_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.piiS096318012000047X
dc.source.journaltitleCambridge Quarterly of Healthcare Ethics
dc.source.beginpage1
dc.source.endpage10
refterms.dateFOA2020-07-01T19:19:09Z


Files in this item

Thumbnail
Name:
SARS-CoV-2_COVID-19_Vaccine ...
Size:
124.6Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© The Author(s), 2020. Published by Cambridge University Press. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as © The Author(s), 2020. Published by Cambridge University Press. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/).